MRVI INVESTIGATION NOTICE: Investigation Launched into Maravai LifeSciences Holdings, Inc. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

Core Insights - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Maravai LifeSciences Holdings, Inc. This investigation focuses on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1][2] Company Overview - Maravai LifeSciences Holdings, Inc. is a provider of biologics that support clinical research [2] Recent Developments - On February 25, 2025, Maravai announced a delay in its earnings release and call, which was originally scheduled for the same day, due to the need for additional time to complete its financial close process. Following this announcement, Maravai's stock price fell nearly 22% [3]